Carboanhydrase IV (CA IV), another CA isoenzyme, was proposed as a potential target antigen in AIP, with AIP patients having a higher prevalence of elevated anti-CA IV compared to normal controls [69]. This evidence concerns the gene CA4 and autoimmune pancreatitis.